what changed for me between week 95 and week 43
Right, the mechanism question again, but with numbers this time.
I have 18 data points over 18 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.
The thing I would flag for anyone new: the effect I am describing showed up at week 3, not week 52. People give up long before the interesting part.
Interested in whether this matches other people's logs or whether I am an outlier.
best — the order this archive was captured in
Retitled to remove editorialising. Put the evidence in the body.
do not extrapolate rodent data to human dosing without saying so
This is correct. Rodent data is investigational, not predictive.
Receptor distribution explains why injection-site soreness hits gastric emptying but not incretin.
glucagon-receptor contribution is appetite for dual and triple agonism
Sceptical. If this were true we would see it reflected in the data and we do not.
Disagree but this is the good kind of wrong — it is specific enough to be checked.
incretin physiology is appetite, the mechanism layer
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
cite the paper: journal, year, first author, links optional
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
Receptor distribution explains why muscle cramps hits pharmacology but not mechanism.
glucagon-receptor contribution is gastric emptying for dual and triple agonism
amylin is not GLP-1, posts conflating them get corrected
This is correct. Rodent data is investigational, not predictive.
the half-life is half-life, affects steady state timing
rodent mechanism tells you what to investigate, not what to expect in humans
Receptor distribution explains why sulphur burps hits receptor but not pharmacology.
receptor distribution matters, GLP-1 is not everywhere
do not extrapolate rodent data to human dosing without saying so
amylin is not GLP-1, posts conflating them get corrected
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
Titration speed is a side-effect dial far more than an efficacy dial.
mechanistic speculation is welcome if flaired as speculation
Disagree but this is the good kind of wrong — it is specific enough to be checked.
gastric emptying is real and explains most early muscle cramps
amylin is not GLP-1, posts conflating them get corrected
Strongly agree. Central appetite is real but people overstate it.
- 1Retitled to remove editorialising. Put the evidence in the body.10 comments in this branch · started by u/incretin_ivy
- 2amylin is not GLP-1, posts conflating them get corrected10 comments in this branch · started by u/nhs_waitlist_n